首页> 外文学位 >Targeted killing of bacteria by conjugation of a soluble photosensitizer to an antimicrobial peptide: Principles and mechanisms.
【24h】

Targeted killing of bacteria by conjugation of a soluble photosensitizer to an antimicrobial peptide: Principles and mechanisms.

机译:通过将可溶性光敏剂与抗菌肽结合来有针对性地杀死细菌:原理和机理。

获取原文
获取原文并翻译 | 示例

摘要

Antimicrobial peptides (AMPs) and photosensitizers (PS) have gained attention as potential alternatives to traditional antibiotics for the treatment of microbial infection due to the decreased likelihood for acquired resistance. However, many AMPs and PS suffer from insufficient activity, specificity, or a combination thereof. AMPs can require high concentrations for effective activity, leading to non-specific side effects and increased costs. PS, on the other hand, are quite active, but are typically hydrophobic and suffer from non-specific binding and damage to host tissues. To solve these problems, we report a novel PS-AMP construct of the soluble PS eosin Y conjugated to the selective AMP (KLAKLAK)2. Eosin Y has a high singlet oxygen quantum yield, which is suitable for photodynamic activity, although the solubility of eosin Y results in poor binding and activity toward membranes on its own. On the other hand, the specificity of (KLAKLAK)2 is high for an AMP, but could still benefit from enhanced activity at lower concentrations. The killing activity and binding specificity of eosin-(KLAKLAK)_(2) toward both bacteria and mammalian cells was assessed using microbiology, biochemistry, and fluorescence microscopy techniques. Additionally, the mechanism of eosin-(KLAKLAK) 2 activity was investigated using liposome models to determine factors involved in binding and membrane disruption. Furthermore, novel applications of transmission electron microscopy (TEM) methods were employed to observe the photodynamic effects of eosin-(KLAKLAK)2 against bacteria.;The PS-AMP conjugate eosin-(KLAKLAK)2 displays synergistic activity between PS and AMP in model liposome systems, and is capable of killing several clinically relevant bacteria, including the multi-drug resistant Acinetobacter baumannii AYE strain. Furthermore, bacterial killing is achieved in the presence of red blood cells (RBCs) and other mammalian cell lines without significant toxicity. Liposome models reveal that the lipid composition of bacteria is a potential factor responsible for the observed binding specificity and corresponding activity. Additionally, TEM methods show that eosin-(KLAKLAK)2 causes extensive membrane damage to both Gram positive Staph aureus and Gram negative Escherichia coli, indicating a primary cause of cell death. A model is proposed where the activities of the PS and AMP, respectively, facilitate the activity of one another, leading to enhanced membrane disruption, and effective antibacterial activity while maintaining cell selectivity.
机译:由于获得性耐药的可能性降低,抗菌肽(AMP)和光敏剂(PS)作为传统抗生素治疗微生物感染的潜在替代品而受到关注。然而,许多AMP和PS遭受不足的活性,特异性或其组合。 AMP可能需要高浓度才能有效发挥作用,从而导致非特异性副作用并增加成本。另一方面,PS活性很高,但通常是疏水性的,并且受到非特异性结合和对宿主组织的损害。为了解决这些问题,我们报道了一种新型的PS-AMP构建的可溶性PS曙红Y偶联到​​选择性AMP(KLAKLAK)2。曙红Y具有很高的单线态氧量子产率,适用于光动力活性,尽管曙红Y的溶解性导致其对膜的结合和活性很差。另一方面,(KLAKLAK)2对AMP的特异性很高,但仍可受益于较低浓度下增强的活性。使用微生物学,生物化学和荧光显微镜技术评估了曙红-(KLAKLAK)_(2)对细菌和哺乳动物细胞的杀伤活性和结合特异性。另外,使用脂质体模型研究了曙红-(KLAKLAK)2活性的机制,以确定参与结合和膜破坏的因子。此外,利用透射电子显微镜(TEM)方法的新应用来观察曙红-(KLAKLAK)2对细菌的光动力作用。PS-AMP共轭曙红-(KLAKLAK)2在模型中显示出PS和AMP之间的协同活性。脂质体系统,并能够杀死几种临床相关细菌,包括多重耐药性鲍曼不动杆菌AYE菌株。此外,在存在红血球(RBC)和其他哺乳动物细胞系而没有明显毒性的情况下,可以实现细菌杀灭。脂质体模型显示细菌的脂质组成是导致观察到的结合特异性和相应活性的潜在因素。另外,TEM方法显示,曙红-(KLAKLAK)2对革兰氏阳性金黄色葡萄球菌和革兰氏阴性大肠杆菌均引起广泛的膜损伤,表明细胞死亡的主要原因。提出了一种模型,其中PS和AMP的活性分别促进彼此的活性,从而导致膜破坏增强和有效的抗菌活性,同时保持细胞选择性。

著录项

  • 作者

    Johnson, Gregory Andrew.;

  • 作者单位

    Texas A&M University.;

  • 授予单位 Texas A&M University.;
  • 学科 Chemistry Biochemistry.;Biophysics General.;Biology Microbiology.
  • 学位 Ph.D.
  • 年度 2013
  • 页码 114 p.
  • 总页数 114
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号